Literature DB >> 29935947

Add-on therapy with traditional Chinese medicine: An efficacious approach for lipid metabolism disorders.

Ying Zhang1, Hiroko Kishi1, Sei Kobayashi2.   

Abstract

Add-on therapy with traditional Chinese medicine (TCM) has been extensively researched in the intractable diseases, such as asthma, cancer, and Alzheimer's disease. As an entirely new concept, add-on therapy of TCM has been also used to prevent and treat hyperlipidemia via lowering cholesterol level. However, the efficacy of add-on therapy with TCM for mediating lipid metabolism disorders remains controversial. In this review, we summarize and provide strong evidence that add-on therapy of TCM as a novel approach is efficacious and safe for hyperlipidemia associated diseases based on the mediation of lipid metabolism disorders.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Berberine; Combination therapy; Curcumin; Hyperlipidemia; Lowering-cholesterol

Mesh：

Substances：

Year:  2018        PMID： 29935947     DOI： 10.1016/j.phrs.2018.06.004

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN： 1043-6618            Impact factor:   7.658


  6 in total

1.  Comparative and Combined Effects of Epigallocatechin-3-gallate and Caffeine in Reducing Lipid Accumulation in Caenorhabditis elegans.

Authors:  Yan Wang; Yu-Fan Xiang; Ai-Lin Liu
Journal:  Plant Foods Hum Nutr       Date:  2022-05-28       Impact factor: 3.921

2.  Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway.

Authors:  Xue Tian; Xu Chen; Qianqian Jiang; Qianbin Sun; Tiantian Liu; Yiqin Hong; Yawen Zhang; Yanyan Jiang; Mingyan Shao; Ran Yang; Chun Li; Qiyan Wang; Yong Wang
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.810

Review 3.  Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects.

Authors:  Ying Hu; Xingjuan Chen; Mu Hu; Dongwei Zhang; Shuo Yuan; Ping Li; Ling Feng
Journal:  Chin Med       Date:  2022-09-29       Impact factor: 4.546

4.  Tartary Buckwheat (Fagopyrum tataricum) Ameliorates Lipid Metabolism Disorders and Gut Microbiota Dysbiosis in High-Fat Diet-Fed Mice.

Authors:  Ang Li; Jin Wang; Yuanyifei Wang; Bowei Zhang; Zhenjia Chen; Junling Zhu; Xiaowen Wang; Shuo Wang
Journal:  Foods       Date:  2022-09-29

5.  Integrating Constituents Absorbed into Blood, Network Pharmacology, and Quantitative Analysis to Reveal the Active Components in Rubus chingii var. suavissimus that Regulate Lipid Metabolism Disorder.

Authors:  Man-Jing Jiang; Wan-Fang Huang; Shuai Huang; Yi-Xiang Lu; Yong Huang; Pei-Lin Du; Yao-Hua Li; Lan-Lan Fan
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

Review 6.  Efficacy and safety assessment of traditional Chinese medicine for metabolic syndrome.

Authors:  Haoran Wu; Jiaxing Tian; Dan Dai; Jiangquan Liao; Xinmiao Wang; Xiuxiu Wei; Xuedong An; Fengmei Lian; Xiaolin Tong
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.